On July 5, 2023, after the market closed, Waldencast filed a current report with the SEC in which it disclosed, among other things that certain financial statements of Obagi, a company that it had acquired, could no longer be relied upon because Waldencast expected to restate those financial statements.
On this news, the price of Waldencast stock fell $0.76 from a closing price of $7.39 per share on July 5, 2023 to a closing price of $6.63 on July 6, 2023, a 10.2% drop.